De-escalation Study for Stage IIa/IIb < 3 cm Seminoma
Learn more about:
Related Clinical Trial
De-escalation Study for Stage IIa/IIb < 3 cm Seminoma
Cardiac Function and Cardiovascular Risk Profile in Testicular Cancer Patients
Therapeutic Strategy Guided by PET-TDM for Patients With Seminoma
Epigenetic Integrity of Spermatozoa in Patients With Germinal Testicular Tumours
Adjuvant Bleomycin, Etoposide and Cisplatin (BEP) Versus Carboplatin in Stage I Seminomatous Testicular Cancer